Interchange Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Interchange Capital Partners's AMGN Position: Q1 2026 in Review
Interchange Capital Partners reduced its Amgen (AMGN) stake by 27% in Q1 2026, selling an estimated $216K and leaving 1,636 shares worth $517K. The position accounts for 0.16% of the portfolio, ranked #137.
Interchange Capital Partners first reported a position in AMGN in Q4 2020 and has held it in 20 quarters since. The position peaked at $880K in Q1 2023. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Interchange Capital Partners held 1,636 shares of Amgen worth $517K as of Q1 2026.
- Interchange Capital Partners sold 606 Amgen shares in Q1 2026, an estimated $216K.
- Amgen made up 0.16% of Interchange Capital Partners's portfolio in Q1 2026, its #137 holding.
- Interchange Capital Partners first reported a position in Amgen in Q4 2020 and has held it in 20 quarters since.
- Interchange Capital Partners's Amgen position peaked at $880K in Q1 2023.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.